E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway

Cancer Research

Volumn 56, Issue 20, 1996, Pages 4620-4624

  Boyer, Sarah N ^a   Wazer, David E ^a   Band, Vimla ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEASOME; RETINOBLASTOMA PROTEIN; UBIQUITIN;

ARTICLE; CELL CYCLE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; RETINOBLASTOMA; VIRUS CARCINOGENESIS; WART VIRUS;

BREAST; CELL LINE, TRANSFORMED; CYSTEINE ENDOPEPTIDASES; EPITHELIAL CELLS; EPITHELIUM; FEMALE; HUMANS; MULTIENZYME COMPLEXES; ONCOGENE PROTEINS, VIRAL; PROTEASOME ENDOPEPTIDASE COMPLEX; RETINOBLASTOMA PROTEIN; UBIQUITINS;

EID: 0029834371     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Weinberg, R. A. The retinoblastoma protein and cell cycle control. Cell, 81 323-330, 1995.
2. Hollingsworth, R. E , Chen, P-L., and Lee, W-H. Integration of cell cycle control with transcriptional regulation by the retinoblastoma protein. Curr Opin Cell Biol., 5: 194-200, 1993.
3. DeCaprio, J. A , Ludlow, J. W., Lynch, D , Furukawa, Y., Griffin, J., Piwnica-Worms, H , Huang, C. M., and Livingston, D. M. The product of the retinoblastoma gene has properties of a cell cycle regulatory element. Cell, 58: 1085-1095, 1989.
4. Chellappan, S P., Hiebert, S., Mudryl, M , Horowitz, J. M., and Nevins, J. R. The E2F transcription factor is a cellular target for the RB protein. Cell, 65 1053-1061, 1991.
5. Whyte, P , Buchkovich, K. J., Horowitz, J. M , Friend, S. H., Raybuck, M., Weinberg, R. A , and Harlow, E Association between an oncogene the adenovirus ElA proteins bind to the retinoblastoma gene product. Nature (Lond ), 334: 124-129, 1988.
6. Ludlow, J. W., DeCaprio, J. A , Huang, C. M., Lee, W. H., Paucha, E., and Livingston, D M SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family. Cell, 56 57-65, 1989.
7. Dyson, N., Howley, P. M., Munger, K., and Harlow, E The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science (Washington DC), 243: 934-940, 1989.
8. Wazer, D. E , Liu, X. L , Chu, Q , Gao, Q. and Band, V Immortalization of distinct human mammary epithelial cell types by human papilloma virus 16 E6 or E7. Proc. Natl. Acad. Sci USA, 92: 3687-3691, 1995
9. Demers, G. W., Foster, S A , Halbert, C. L and Galloway, D. A. Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7. Proc. Natl. Acad. Sci. USA, 91: 4382-4386, 1994.
10. Yeager, T , Stadler, W., Belair, C., Puthenveettil, J , Olopade, O. and Reznikoff, C Increased p16 level correlate with pRb alterations in human uroepithehal cells. Cancer Res., 55: 493-497, 1995.
11. Band, V , and Sager, R. Distinctive traits of normal and tumor-derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types. Proc Natl Acad. Sci USA, 86: 1249-1253, 1989.
12. Chowdary, D. R., Dermody, J. J., Jha, K. K., and Ozer, H. L. Accumulation of p53 in a mutant cell line defective in the ubiquitin pathway. Mol. Cell. Biol , 14: 1997-2003, 1994.
13. Band, V., Dalai, S., Delmolmo, L , and Androphy, E. J. Enhanced degradation of p53 protein in HPV-6 and BPV-1 E6-immortalized human mammary epithelial cells. EMBO J., 12: 1847-1852, 1993.
14. Maki, C. G , Huibregtse, J. M., and Howley, P M. In vitro ubiquitination and proteasome-mediated degradation of p53. Cancer Res., 56: 2649-2654, 1996.
15. Pagano, M., Tam, S. W., Theodoras, A M , Beer-Romano, P., Del Sal, G., Chau, V , Yew, P. R , Draetta, G. F., and Rolfe, M. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27 Science (Washington DC), 269: 682-685, 1995.
16. Scheffner, M., Huibregtse, J M , Vierstra, R D., and Howley, P. M. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53 Cell, 75: 495-505, 1993.
17. Ciechanover, A. J., DiGiuseppe, J. A., Bercovich, B., Orian, A., Richter, J. D., Schwartz, A. L., and Brodeur, G. M. Degradation of nuclear oncoproteins by the ubiquitin system in vitro. Proc. Natl. Acad Sci. USA, 88: 139-143, 1991.
18. Rock, K. L , Gramm, C., Rothstem, L., Clark, K., Stein, R., Dick, L., Hwang, D., and Goldberg, A. L Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class 1 molecules. Cell, 78: 761-771, 1994.
19. Scheffner, M., Munger, K., Huibregtse, J M , and Howley, P M. Targeted degradation of the retinoblastoma protein by human papilloma virus E7-E6 fusion proteins. EMBO J , 11: 2425-2431, 1992.
20. Banks, L , Edmonds, C., and Vousden, K. H. Ability of the HPV16 E7 protein to bind RB and induce DNA synthesis is not sufficient for efficient transforming activity. Oncogene, 5 1383-1389, 1990.
21. Jewers, R. J., Hildebrandt, P., Ludlow, J. W., Kell, B., and McCance, D. J. Regions of HPV16 E7 oncoprotein required for immortalization of human keratinocytes. J. Virol., 66: 1329-1335, 1992.
22. Dalal, S., Gao, Q., Androphy, E J., and Band, V. Mutational analysis of HPV16 E6 demonstrates that p53 degradation is necessary for mammary epithelial cell immortalization. J. Virol., 70 683-688, 1996.
23. An, B., and Dou, Q P. Cleavage of retinoblastoma protein during apoptosis: an interleukin 1β-converting enzyme-like protease as candidate. Cancer Res , 56: 438-442, 1996.